Related references
Note: Only part of the references are listed.Increased EEG sigma and beta power during NREM sleep in primary insomnia
Kai Spiegelhalder et al.
BIOLOGICAL PSYCHOLOGY (2012)
Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties
Paul J. Coleman et al.
CHEMMEDCHEM (2012)
EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia
Jonas Lundahl et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
W. Joseph Herring et al.
NEUROLOGY (2012)
Pharmacological characterization of MK-6096-A dual orexin receptor antagonist for insomnia
Christopher J. Winrow et al.
NEUROPHARMACOLOGY (2012)
Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia
Paolo Bettica et al.
NEUROPSYCHOPHARMACOLOGY (2012)
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter et al.
PHARMACOLOGICAL REVIEWS (2012)
Promotion of Sleep by Suvorexant--A Novel Dual Orexin Receptor Antagonist
Christopher J. Winrow et al.
JOURNAL OF NEUROGENETICS (2011)
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers
S. Otmani et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Catherine Brisbare-Roch et al.
NATURE MEDICINE (2007)
A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers
Ian Hindmarch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Hypothalamic regulation of sleep and circadian rhythms
CB Saper et al.
NATURE (2005)
Sub-chronic administration of zolpidem affects modifications to rat sleep architecture
JJ Renger et al.
BRAIN RESEARCH (2004)
Posttraining increases in REM sleep intensity implicate REM sleep in memory processing and provide a biological marker of learning potential
CT Smith et al.
LEARNING & MEMORY (2004)
Diurnal and nocturnal rodents show rhythms in orexinergic neurons
GS Martínez et al.
BRAIN RESEARCH (2002)
Epidemiology of insomnia: what we know and what we still need to learn
MM Ohayon
SLEEP MEDICINE REVIEWS (2002)
Zolpidem and sleep deprivation:: Different effect on EEG power spectra
HP Landolt et al.
JOURNAL OF SLEEP RESEARCH (2000)
Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors
F Espa et al.
CLINICAL NEUROPHYSIOLOGY (2000)
Share Paper
